Istraživači

Rezultati 21-40 od 179
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2022Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trialTerpos, Evangelos; ...; Bila, Jelena S.  ; ...; (broj koautora 23)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2022Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature reviewJovićević, Vanja; Bila, Jelena S.  ; Mesaroš, Šarlota T.  ; Pekmezović, Tatjana D  ; Drulović, Jelena S. Naučni članak
23M23 - Međunarodni časopis kategorije M23
2022Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo StudyDimopoulos, Meletios A.; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena S.  ;
Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Kampfenkel, Tobias; Liu, Weiping; Kosh, Michele; NamPhuong, Tran; Carson, Robin; Sonneveld, Pieter;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Ultra-high-risk prognostic significance of double and triple hit myelomaBila, Jelena S.  ; Mitrović, Marko; Bukumirić, Zoran M.  ; Jovanović, Jelica V.; Denčić-Fekete, Marija  ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A.  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcomeBeksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S.  ; Ozsan, Hayri;
Ivanaj, Arben; Ibricevic-Balic, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
Ostalo
Mp kategorija će biti prikazana naknadno.
2021Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trialDimopoulos, Meletios Athanasios; ...; Bila, Jelena S.  ; ...; (broj koautora 23)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2021The implication and consequence of CD34+cell/subset quantity/ratio on the clinical outcome of hematologic malignancies treated by autologous stem cell transplantsTodorović, Milena R.  ; Pavlović, Mirjana A.; Bila, Jelena S.  ; Balint, Bela J.  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Prognostic impact of response-adjusted ISS score in Multiple MyelomaMitrović, Marko; Bukumirić, Zoran M.  ; Sretenović, Aleksandra M.; Miketić, Ivana; Bila, Jelena S.  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLOTerpos, Evangelos; ...; Bila, Jelena S.  ; ...; (broj koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston StudyJagannath, Sundar; ...; Bila, Jelena S.  ; ...; (broj koautora 45)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study GroupBila, Jelena S.  ; Katodritou, Eirini; Guenova, Margarita; Basic-Kinda, Sandra; Coriu, Daniel; Dapcevic, Milena; Ibricevic-Balic, Lejla; Ivanaj, Arben; Karanfilski, Oliver; Zver, Samo;
Beksac, Meral; Terpos, Evangelos; Dimopoulos, Meletios Athanassios;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2021Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo StudySonneveld, Pieter; ...; Bila, Jelena S.  ; ...; (broj koautora 21)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)Einsele, Hermann; ...; Bila, Jelena S.  ; ...; (broj koautora 23)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two CasesGerhardt, Kristin; ...; Sretenović, Aleksandra M.; ...; Todorović, Milena R.  ; Bila, Jelena S.  ; ...; Vučinić, VladanNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2020Induction of remission in a heavily pretreated patient with diffuse large B-cell lymphoma (DLBCL) who relapsed after the therapy with CAR-T-cells - case reportKüpper K.; Georgi, Thomas; Bach, Enrica; Leiblein, Sabine; Sretenović, Aleksandra M.; Hoffmann, S.; Tumewu, Theresa; Bila, Jelena S.  ; Franke, Georg-Nikolaus; Platzbecker, Uwe;
Vučinić, Vladan ;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialGrosicki, Sebastian; ...; Bila, Jelena S.  ; ...; (broj koautora 58)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2020Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplantsTodorović-Balint, Milena  ; Bila, Jelena  ; Balint, Bela  ; Jeličić, Jelena ; Đunić, Irena  ; Antić, Darko  ; Kraguljac-Kurtović, Nada ; Vujić, Dragana ; Mihaljević, Biljana Naučni članak
23M23 - Međunarodni časopis kategorije M23
2020A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcomeBeksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S.  ; Ozsan, Hayri;
Ivanaj, Arben; Ibričević-Balić, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2019Ultrastructural and morphometric analysis of enlarged platelets in congenital isolated aspleniaMarković, Olivera  ; Martinović, Tamara  ; Ćirić, Darko  ; Trpinac, Dušan ; Čemerikić-Martinović, Vesna; Bumbaširević, Vladimir ; Bila, Jelena  ; Marisavljević, Dragomir  ; Kravić-Stevović, Tamara  Naučni članak
23M23 - Međunarodni časopis kategorije M23
201825(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it?Đurašinović, Vladislava T.; Mihaljević, Biljana ; Šipetić-Grujičić, Sandra B.  ; Ignjatović, Svetlana  ; Trajković, Goran ; Todorović-Balint, Milena R.  ; Antić, Darko  ; Bila, Jelena S.  ; Anđelić, Boško M.; Jeličić, Jelena J. ;
Vuković, Vojin M. ; Nikolić, Aleksandra M.  ; Klek, Stanislaw;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a